Related Experiment Videos
Endogenous inhibitory mechanisms in asthma
1Department of Thoracic Medicine, National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom. p.j.barnes@ic.ac.uk
American Journal of Respiratory and Critical Care Medicine
|March 11, 2000
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.
The Journal of experimental medicine·1995
Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages.
Journal of immunology (Baltimore, Md. : 1950)·1995
Corticosteroid inhibition of macrophage inflammatory protein-1 alpha in human monocytes and alveolar macrophages.
The American journal of physiology·1995
Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
American journal of respiratory and critical care medicine·1995
Acute exacerbation in fibrotic interstitial lung disease: An International Working Group Report.
American journal of respiratory and critical care medicine·2026
Peripubertal Changes in Asthma.
American journal of respiratory and critical care medicine·2026
Incretins Predict Response to Enteral Nutrition Strategies in the EDEN Trial: A Secondary Analysis.
American journal of respiratory and critical care medicine·2026
Nutrition and Exercise in Critical Illness (NEXIS) trial: randomized trial of combined in-bed cycling and intravenous amino acid plus usual care.
American journal of respiratory and critical care medicine·2026
Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research.
American journal of respiratory and critical care medicine·2026
Mycophenolate and Azathioprine in Fibrotic Interstitial Lung Disease.
American journal of respiratory and critical care medicine·2026
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026